对于宫癌患者来说,FBXO5作为一种新的预后生物标志物

Shan Jiang1,2, Jianfeng Zheng1, Zhaolei Cui3

  • 1Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.

概括

在宫癌 (CC) 中,FBXO5基因的表达很高,并且与患者的生存率较低有关. 它的上调促进了CC细胞的增殖,迁移和入侵,表明它是潜在的治疗点.